A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects

NCT05758818 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Cardiac Repolarization

Interventions

DRUG: Placebo
DRUG: Moxifloxacin (positive control)
DRUG: Milademetan

Sponsor

Rain Oncology Inc